Innova BioSciences

Innova Biosciences is a biotechnology company specializing in bioconjugation and antibody labeling technologies. The company is renowned for its proprietary Lightning-Link platform, which enables the rapid and efficient coupling of antibodies to a wide range of labels, including enzymes, fluorescent proteins, and nanoparticles. These tools are essential for researchers developing diagnostic assays and therapeutic conjugates, such as antibody-drug conjugates (ADCs). By eliminating the need for column chromatography or other separation steps, their technology significantly reduces the time and material loss associated with traditional conjugation methods. In 2017, the company was acquired by Sygnis AG (later rebranded as Expedeon), and its portfolio was eventually integrated into Abcam following a subsequent acquisition in 2020. Today, its technologies continue to serve as a cornerstone for high-sensitivity detection and labeling in the life sciences industry.